Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following conference:
Jefferies Global Healthcare Conference 2026
Dates: June 2–4, 2026
Location: New York, United States
| Press release in English | 120.11 KB |
| Communiqué de presse en français | 104.89 KB |